Lifevantage Net Profit Margin 2012-2026 | LFVN

Lifevantage net profit margin from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Lifevantage Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2026-03-31 $0.20B $0.01B 2.55%
2025-12-31 $0.21B $0.01B 3.33%
2025-09-30 $0.23B $0.01B 4.37%
2025-06-30 $0.23B $0.01B 4.39%
2025-03-31 $0.22B $0.01B 4.05%
2024-12-31 $0.21B $0.01B 3.77%
2024-09-30 $0.20B $0.00B 2.04%
2024-06-30 $0.20B $0.00B 1.50%
2024-03-31 $0.21B $0.00B 1.95%
2023-12-31 $0.21B $0.00B 1.42%
2023-09-30 $0.21B $0.00B 1.41%
2023-06-30 $0.21B $0.00B 1.40%
2023-03-31 $0.21B 0 0.00%
2022-12-31 $0.21B 0 0.00%
2022-09-30 $0.21B $0.00B 0.49%
2022-06-30 $0.21B $0.00B 1.46%
2022-03-31 $0.21B $0.01B 4.29%
2021-12-31 $0.21B $0.01B 4.72%
2021-09-30 $0.22B $0.01B 6.39%
2021-06-30 $0.22B $0.01B 5.88%
2021-03-31 $0.23B $0.01B 5.33%
2020-12-31 $0.23B $0.01B 5.24%
2020-09-30 $0.23B $0.01B 5.19%
2020-06-30 $0.23B $0.01B 5.17%
2020-03-31 $0.23B $0.01B 5.24%
2019-12-31 $0.23B $0.01B 5.24%
2019-09-30 $0.23B $0.01B 3.98%
2019-06-30 $0.23B $0.01B 3.54%
2019-03-31 $0.22B $0.01B 3.13%
2018-12-31 $0.22B $0.01B 3.20%
2018-09-30 $0.21B $0.01B 2.86%
2018-06-30 $0.20B $0.01B 2.96%
2018-03-31 $0.20B $0.00B 1.50%
2017-12-31 $0.19B $0.00B 0.52%
2017-09-30 $0.19B $0.00B 0.52%
2017-06-30 $0.20B $0.00B 0.50%
2017-03-31 $0.20B $0.00B 1.49%
2016-12-31 $0.21B $0.00B 1.88%
2016-09-30 $0.22B $0.01B 2.78%
2016-06-30 $0.21B $0.01B 2.91%
2016-03-31 $0.20B $0.00B 2.02%
2015-12-31 $0.19B $0.00B 2.14%
2015-09-30 $0.18B $0.00B 1.64%
2015-06-30 $0.19B $0.01B 3.68%
2015-03-31 $0.20B $0.01B 4.48%
2014-12-31 $0.21B $0.01B 4.74%
2014-09-30 $0.22B $0.01B 5.58%
2014-06-30 $0.21B $0.01B 4.67%
2014-03-31 $0.21B $0.01B 3.81%
2013-12-31 $0.21B $0.01B 4.39%
2013-09-30 $0.21B $0.01B 2.91%
2013-06-30 $0.21B $0.01B 3.37%
2013-03-31 $0.20B $0.01B 5.97%
2012-12-31 $0.19B $0.00B 2.14%
2012-09-30 $0.16B $0.01B 8.18%
2012-06-30 $0.13B $0.01B 10.32%
2012-03-31 $0.10B $-0.04B -40.63%
2011-12-31 $0.07B $-0.04B -62.86%
2011-09-30 $0.05B $-0.05B -92.31%
2011-06-30 $0.04B $-0.05B -134.21%
2011-03-31 $0.03B $-0.01B -33.33%
2010-12-31 $0.02B $-0.01B -35.00%
2010-09-30 $0.02B $-0.01B -86.67%
2010-06-30 $0.01B $-0.01B -118.18%
2010-03-31 $0.01B $-0.01B -144.44%
2009-12-31 $0.01B $-0.01B -114.29%
2009-09-30 $0.01B $-0.01B -133.33%
2009-06-30 $0.01B $-0.01B -180.00%
2009-03-31 $0.00B $-0.01B -125.00%
2008-12-31 $0.00B $0.00B -75.00%
2008-09-30 $0.00B $0.00B -50.00%
2008-06-30 $0.00B $0.00B -50.00%
2008-03-31 $0.00B $0.00B -50.00%
2007-12-31 $0.00B $0.00B -50.00%
2007-09-30 $0.00B $0.00B -100.00%
2007-06-30 $0.01B $-0.01B -100.00%
2007-03-31 $0.01B $-0.01B -120.00%
2006-12-31 $0.01B $-0.01B -120.00%
2006-09-30 $0.01B $-0.01B -83.33%
2006-06-30 $0.01B $0.00B -57.14%
2006-03-31 $0.01B $0.00B 50.00%
2005-12-31 $0.01B $-0.01B -85.71%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.053B $0.229B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Align Technology (ALGN) United States $12.400B 21.09
Henry Schein (HSIC) United States $8.645B 15.16
Merit Medical Systems (MMSI) United States $4.072B 19.84
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Axe Compute (AGPU) United States $0.022B 0.00